Neurology Alert (Vol. 35, No. 5) - January 1, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: January 2016

Valid through: January 2019

Target Audience

This activity is intended for the neurologist.

Subjects

  • Clinical Features and Treatment Response in Patients with NMO Spectrum Disorders
  • Disability, Anxiety, and Depression with Medication-overuse Headache
  • Simvastatin and Vitamin D for Migraine Prevention
  • Acetylcholine Receptor Antibody Testing in Ocular Myasthenia GravisVision Problems After Ischemic Stroke: Effects on Quality of Life
  • Left Atrial Dysfunction Without Fibrillation Increases Stroke Risk
  • Loss of Consciousness at Onset of Aneurysmal SAH: Poor Prognosis
  • Small Vessel Disease Often Accompanies Large Vessel Intracranial Atherosclerosis

Objectives

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Jai S. Perumal, MD, Assistant Professor of Neurology, Weill Cornell Medical College

Louise M. Klebanoff, MD, Assistant Professor of Clinical Neurology, Weill Cornell Medical College

Dara Jamieson, MD, Associate Professor of Clinical Neurology, Weill Cornell Medical College

Michael Rubin, MD, Professor of Clinical Neurology, Weill Cornell Medical College

Marc Dinkin, MD, Assistant Professor of Ophthalmology, Weill Cornell Medical College

Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

Editors

Medical Editor: Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

AHC Media Executive Editor: Leslie G. Coplin

Managing Editor: Jonathan Springston

Financial Disclosure

Author Jai S. Perumal, MD reports she receives grant/research support from Genzyme Corp. and is on the speakers bureau for Biogen Idec, Teva Pharmaceuticals, Genzyme Corp. and Acorda Therapeutics. Author Dara Jamieson, MD reports she is a consultant for Bayer and Boehringer-Ingelheim. Editor Matthew E. Fink, MD reports he is a retained consultant for Procter & Gamble and Pfizer.  

Authors Louise M. Klebanoff, MD; Michael Rubin, MD; and Marc Dinkin, MD; report no financial relationships relevant to this field of study.

Neurology Alert's editor in chief, Matthew E. Fink, MD reports he is a retained consultant for Procter & Gamble and Pfizer. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2016, AHC Media. All rights reserved.